Tissue concentrations of MPTP and MPP+ in relation to catecholamine depletion after the oral or subcutaneous administration of MPTP to mice
- 31 December 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (22) , 2077-2083
- https://doi.org/10.1016/0024-3205(89)90072-6
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrineBiochemical Pharmacology, 1988
- Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP): Differential effects on depletion of heart norepinephrine and of striatal dopamine in miceBiochemical Pharmacology, 1987
- Depletion of cardiac norepinephrine in rats and mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Biochemical Pharmacology, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Colorimetric assay for monoamine oxidase in tissues using peroxidase and 2,2′-azinodi(3-ethylbenzthiazoline-6-sulfonic acid) as chromogenAnalytical Biochemistry, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984